SCHEMBL7069396

SCHEMBL7069396

CCCOC(=O)C(Cc1ccc(OCc2cnc3ccc(OC)cc3c2OC(C)C)cc1)C(=O)OCCC

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 4/20 0.40
SMN1; SMN2 Q16637 3/20 0.40
THRB P10828 1/20 0.40
PLA2G2A P14555 2/20 0.36
ALDH1A1 P00352 2/20 0.36
LMNA P02545 2/20 0.36
KDM4E B2RXH2 1/20 0.36
HPGD P15428 1/20 0.36
TDP1 Q9NUW8 1/20 0.36
PPARG P37231 3/20 0.36
PPARD Q03181 2/20 0.36
PPARA Q07869 2/20 0.36
NMT1 P30419 2/20 0.36
KMT2A Q03164 1/20 0.36
MTNR1A P48039 1/20 0.36
MTNR1B P49286 1/20 0.36
TP53 P04637 1/20 0.35
MAOB P27338 2/20 0.35
EDNRA P25101 1/20 0.35
LDHA P00338 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7070700 0.96 MAPT (0.39) MAPTSMN1; SMN2THRBPLA2G2AALDH1A1
SCHEMBL7070604 0.93 MAPT (0.44) MAPTSMN1; SMN2THRBALDH1A1LMNA
SCHEMBL7071902 0.91 PPARG (0.43) MAPTSMN1; SMN2THRBALDH1A1LMNA
Hydrochloric Acid SCHEMBL7066556 0.90 PPARG (0.42) MAPTSMN1; SMN2THRBALDH1A1LMNA
SCHEMBL7070398 0.89 MAPT (0.42) MAPTSMN1; SMN2THRBALDH1A1LMNA
SCHEMBL7069467 0.88 MAPT (0.39) MAPTSMN1; SMN2THRBALDH1A1LMNA
SCHEMBL7066025 0.88 MAPT (0.40) MAPTSMN1; SMN2THRBALDH1A1LMNA
SCHEMBL7070064 0.88 MAPT (0.42) MAPTSMN1; SMN2THRBALDH1A1LMNA
SCHEMBL7072767 0.87 MAPT (0.41) MAPTSMN1; SMN2THRBALDH1A1LMNA
SCHEMBL7070060 0.86 MAPT (0.40) MAPTSMN1; SMN2THRBALDH1A1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20030212100-A1 Quinoline derivatives and medicinal use thereof MITSUI CHEMICALS, INC. (JP) 2003-11-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030212100-A1 Quinoline derivatives and medicinal use thereof PPARG, PPARD, PPARA MAPT 2433/4885SMN1; SMN2 3691/4885THRB 956/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.